Table 1.
Case |
Sex | Age (years) |
Cause of death | Postmortem delay (h) |
Braak stage |
CERAD stage |
Neuropsychological diagnosis |
---|---|---|---|---|---|---|---|
AB1 | Male | 45 | Lung cancer | <1 | 0 | 0 | No recorded neurologic alterations |
AB3 | Male | 53 | Bladder carcinoma | 3.5 | 0 | 0 | No recorded neurologic alterations |
IF10 | Male | 66 | Bronchopneumonia and cardiac failure |
2 | 0 | 0 | No recorded neurologic alterations |
M16 | Male | 40 | Traffic accident | 3 | 0 | 0 | No recorded neurologic alterations |
IF1 | Female | 80 | - | 2 | IV | B | No evidence of cognitive impairment and dementia |
VK11 | Female | 87 | Respiratory inflammation | 1.5 | III−IV | A | Dementia |
VK16 | Female | 88 | - | 2.5 | VI | C | Dementia |
VK22 | Female | 86 | - | 2 | V | C | Dementia |
Braak stages (Braak and Braak, 1991): III, NFTs in EC and closely related areas; III−IV, NFTs abundant in amygdala and hippocampus; extending slightly into association cortex; V−VI, NFTs widely distributed throughout the neocortex and ultimately involving primary motor and sensory areas. CERAD stages (Mirra et al., 1991): A, low density of neuritic plaques; B, intermediate density of neuritic plaques; C, high density of neuritic plaques. -, not available.